ACE and Hypertension: There was no statistically significant difference in nAb response rates or in nAb titers between those with hypertension on an ARB and/or ACE inhibitor medication (n = 49 of 75 with hypertension) and those with hypertension who were not on these medications (n = 26 of 75) (ID50: OR = 0.65, p = 0.54; GMR = 0.87, p = 0.777; ID80: OR = 0.65, p = 0.554; GMR = 0.84, p = 0.626; Table J in S1 Data).